Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(27)
DRUG(5)
RADIATION(4)
OTHER(1)
Questionnaire Administration
5 trials
not_applicablephase_2
jonsson-comprehensive-cancer-center
Stereotactic Body Radiation Therapy
4 trials
not_applicablephase_2
jonsson-comprehensive-cancer-center
Biospecimen Collection
3 trials
not_applicablephase_2
jonsson-comprehensive-cancer-center
CT-guided Stereotactic Body Radiation Therapy
2 trials
not_applicable
jonsson-comprehensive-cancer-center
Apalutamide
2 trials
phase_2
jonsson-comprehensive-cancer-center
Gallium Ga 68 Gozetotide
2 trials
phase_2
jonsson-comprehensive-cancer-center
Quality-of-Life Assessment
2 trials
not_applicablephase_2
jonsson-comprehensive-cancer-center
Computed Tomography
2 trials
not_applicablephase_2
jonsson-comprehensive-cancer-center

+15 more interventions

23 unique interventions4 categories

Analytics

Trial Phases

Phase 24

Trial Status

Recruiting2
Other5

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT07150715Phase 2Recruiting
Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma
Oligometastatic Prostate AdenocarcinomaRecurrent Prostate Adenocarcinoma
PrincipalinvestigatorStart date: 2025-12-12
NCT06995053Not ApplicableActive Not Recruiting
Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial
Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more
PrincipalinvestigatorStart date: 2025-06-27
NCT06067269Phase 2Recruiting
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial
Prostate AdenocarcinomaStage II Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8+1 more
PrincipalinvestigatorStart date: 2024-03-28
NCT04915508Phase 2Active Not Recruiting
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy
Prostate AdenocarcinomaStage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIIC Prostate Cancer AJCC v8+3 more
PrincipalinvestigatorStart date: 2021-06-23
NCT03902951Phase 2Active Not Recruiting
Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer
Metastatic Prostate AdenocarcinomaProstate Adenocarcinoma With Focal Neuroendocrine DifferentiationRecurrent Prostate Carcinoma+1 more
PrincipalinvestigatorStart date: 2021-03-17
NCT04624256Not ApplicableActive Not Recruiting
Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial
Prostate AdenocarcinomaStage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8+3 more
PrincipalinvestigatorStart date: 2020-11-10
NCT04384770Active Not Recruiting
CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Cancer, MIRAGE Study
Prostate Adenocarcinoma
PrincipalinvestigatorStart date: 2020-05-12

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeremie Calais

UCLA / Jonsson Comprehensive Cancer Center

Related
9 trials

Shared therapeutic areas:

Recurrent Prostate CarcinomaStage IVA Prostate Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8+11 more

Worked with same sponsors:

Jonsson Comprehensive Cancer CenterNovartis Pharmaceuticals
Similarity Score20%

Lorna McNeill

M.D. Anderson Cancer Center

Related
6 trials

Shared therapeutic areas:

Stage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8+6 more
Similarity Score13%

Michael Schweizer

Fred Hutch/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8Metastatic Prostate Adenocarcinoma+4 more

Worked with same sponsors:

Janssen Scientific Affairs, LLC
Similarity Score10%

Robert Montgomery

Fred Hutch/University of Washington Cancer Consortium

Related
6 trials

Shared therapeutic areas:

Prostate AdenocarcinomaRecurrent Prostate CarcinomaStage I Prostate Cancer AJCC v8+4 more
Similarity Score10%

Siqing fu

M.D. Anderson Cancer Center

Related
6 trials

Shared therapeutic areas:

Stage III Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8Stage IIIB Prostate Cancer AJCC v8+4 more
Similarity Score10%

Carlos E. Vargas, M.D.

Mayo Clinic

Related
5 trials

Shared therapeutic areas:

Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+3 more
Similarity Score9%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8Recurrent Prostate Carcinoma+2 more

Worked with same sponsors:

Janssen Scientific Affairs, LLC
Similarity Score7%

A P Chen

National Cancer Institute LAO

Related
8 trials

Shared therapeutic areas:

Recurrent Prostate CarcinomaStage III Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8
Similarity Score4%

Jeremie Calais, MD

UCLA / Jonsson Comprehensive Cancer Center

Related
5 trials

Shared therapeutic areas:

Stage IVB Prostate Cancer AJCC v8Recurrent Prostate CarcinomaStage IVA Prostate Cancer AJCC v8

Worked with same sponsors:

Jonsson Comprehensive Cancer CenterNovartis Pharmaceuticals
Similarity Score4%

David Woodrum, MD, PhD

Mayo Clinic

Related
5 trials

Shared therapeutic areas:

Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT07150715Phase 2PrincipalInvestigator

Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma

Oligometastatic Prostate AdenocarcinomaRecurrent Prostate Adenocarcinoma
Recruiting
NCT06995053Not ApplicablePrincipalInvestigator

Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial

Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more
Active Not Recruiting
NCT06067269Phase 2PrincipalInvestigator

Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial

Prostate AdenocarcinomaStage II Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8+1 more
Recruiting
NCT04915508Phase 2PrincipalInvestigator

Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy

Prostate AdenocarcinomaStage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIIC Prostate Cancer AJCC v8+3 more
Active Not Recruiting
NCT03902951Phase 2PrincipalInvestigator

Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer

Metastatic Prostate AdenocarcinomaProstate Adenocarcinoma With Focal Neuroendocrine DifferentiationRecurrent Prostate Carcinoma+1 more
Active Not Recruiting
NCT04624256Not ApplicablePrincipalInvestigator

Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial

Prostate AdenocarcinomaStage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8+3 more
Active Not Recruiting
NCT04384770PrincipalInvestigator

CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Cancer, MIRAGE Study

Prostate Adenocarcinoma
Active Not Recruiting

All 7 trials loaded